Business Description
![Avivagen Inc Avivagen Inc logo](https://static.gurufocus.com/logos/0C00000JIZ.png?14)
Avivagen Inc
NAICS : 325412
SIC : 3741
ISIN : CA05382F2026
Description
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -33.94 | |||||
Debt-to-Equity | -0.78 | |||||
Debt-to-EBITDA | -2.67 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -310.32 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | 17.5 | |||||
3-Year EPS without NRI Growth Rate | 34.7 | |||||
3-Year FCF Growth Rate | 23.7 | |||||
3-Year Book Growth Rate | 5.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -66.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.03 | |||||
Quick Ratio | 0.02 | |||||
Days Inventory | 302.33 | |||||
Days Sales Outstanding | 74.43 | |||||
Days Payable | 812.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30.3 | |||||
Shareholder Yield % | 600.57 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.74 | |||||
Operating Margin % | -228.63 | |||||
Net Margin % | -648.05 | |||||
FCF Margin % | -102.37 | |||||
ROA % | -553.57 | |||||
ROIC % | -52.49 | |||||
ROC (Joel Greenblatt) % | -3517.72 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.33 | |||||
EV-to-EBIT | -2.74 | |||||
EV-to-EBITDA | -2.8 | |||||
EV-to-Revenue | 10.63 | |||||
EV-to-FCF | -10.38 | |||||
Price-to-Median-PS-Value | 0.01 | |||||
Earnings Yield (Greenblatt) % | -36.5 | |||||
FCF Yield % | -188.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avivagen Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.716 | ||
EPS (TTM) (C$) | -0.06 | ||
Beta | 1.13 | ||
Volatility % | 57.52 | ||
14-Day RSI | 0 | ||
14-Day ATR (C$) | 0.000007 | ||
20-Day SMA (C$) | 0.005 | ||
12-1 Month Momentum % | -66.67 | ||
52-Week Range (C$) | 0.005 - 0.02 | ||
Shares Outstanding (Mil) | 77.69 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Avivagen Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Avivagen Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Avivagen Inc Frequently Asked Questions
What is Avivagen Inc(TSXV:VIV.H)'s stock price today?
The current price of TSXV:VIV.H is C$0.01. The 52 week high of TSXV:VIV.H is C$0.02 and 52 week low is C$0.01.
When is next earnings date of Avivagen Inc(TSXV:VIV.H)?
The next earnings date of Avivagen Inc(TSXV:VIV.H) is .
Does Avivagen Inc(TSXV:VIV.H) pay dividends? If so, how much?
Avivagen Inc(TSXV:VIV.H) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |